Interleukin-10 regulates TNF-α-converting enzyme (TACE/ADAM-17) involving a TIMP-3 dependent and independent mechanism

被引:39
作者
Brennan, Fionula M. [1 ]
Green, Patricia [1 ]
Amjadi, Parisa [1 ]
Robertshaw, Heidi J. [1 ]
Alvarez-Iglesias, Montserrat [2 ]
Takata, Masao [2 ]
机构
[1] Imperial Coll, Fac Med, Kennedy Inst Rheumatol Div, London W6 8LH, England
[2] Imperial Coll London, Dept Anaesthesia Pain Med & Intens Cate, Fac Med, London, England
基金
英国惠康基金;
关键词
IL-10; inflammation; TNF; TNF-alpha-converting enzyme;
D O I
10.1002/eji.200737821
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-10 is a potent anti-inflammatory molecule, which regulates TNF-alpha at multiple levels. We investigated whether IL-10 also modulated the activity of the TNF-alpha-converting enzyme (TACE). Using an ex vivo fluorogenic assay we observed that LPS rapidly induced TACE activity in monocytes coinciding with release of soluble TNF-alpha. In the presence of IL-10, TNF-a production and activation of surface TACE was significantly inhibited. Paradoxically, both LPS with or without IL-10 led to accumulation of surface TACE (albeit catalytically inactive) over a 24 h period. We investigated whether this was mediated through induction of endogenous tissue inhibitor metalloproteinase-3 (TIMP-3). We found that the inhibition of TACE activity at 2 h by IL-10 was not TIMP-3 dependent but that the late accumulation of surface TACE was prevented with TIMP-3 antibodies. Furthermore, induction of endogenous TIMP-3 was observed by western blotting in both LPS- and in LPS with IL-10-treated monocytes from 6 to 8 h of culture. These results indicate that IL-10 further regulates TNF-a by modulating TACE activation at early time points and by contributing to the induction of TIMP-3, the natural inhibitor of active TACE, at later time points. These observations add to our understanding of inflammation and the importance of homeostatic regulators of these events.
引用
收藏
页码:1106 / 1117
页数:12
相关论文
共 52 条
[1]   Shedding of interleukin-6 receptor and tumor necrosis factor α -: Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins [J].
Althoff, K ;
Reddy, P ;
Voltz, N ;
Rose-John, S ;
Müllberg, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (09) :2624-2631
[2]   Continuous real-time measurement of tumor necrosis factor-α converting enzyme activity on live cells [J].
Alvarez-Iglesias, M ;
Wayne, G ;
O'Dea, KP ;
Amour, A ;
Takata, M .
LABORATORY INVESTIGATION, 2005, 85 (11) :1440-1448
[3]   TNF-α converting enzyme (TACE) is inhibited by TIMP-3 [J].
Amour, A ;
Slocombe, PM ;
Webster, A ;
Butler, M ;
Knight, CG ;
Smith, BJ ;
Stephens, PE ;
Shelley, C ;
Hutton, M ;
Knäuper, V ;
Docherty, AJP ;
Murphy, G .
FEBS LETTERS, 1998, 435 (01) :39-44
[4]   A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].
Black, RA ;
Rauch, CT ;
Kozlosky, CJ ;
Peschon, JJ ;
Slack, JL ;
Wolfson, MF ;
Castner, BJ ;
Stocking, KL ;
Reddy, P ;
Srinivasan, S ;
Nelson, N ;
Boiani, N ;
Schooley, KA ;
Gerhart, M ;
Davis, R ;
Fitzner, JN ;
Johnson, RS ;
Paxton, RJ ;
March, CJ ;
Cerretti, DP .
NATURE, 1997, 385 (6618) :729-733
[5]  
BLENIS J, 1984, J BIOL CHEM, V259, P1563
[6]   Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus -: Metalloproteinase inhibition is associated with proapoptotic activity [J].
Bond, M ;
Murphy, G ;
Bennett, MR ;
Amour, A ;
Knäuper, V ;
Newby, AC ;
Baker, AH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) :41358-41363
[7]  
Brennan FM, 2002, ARTHRITIS RHEUM, V46, P31, DOI 10.1002/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO
[8]  
2-5
[9]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[10]   Tumour necrosis factor-α stimulates expression of TNF-α converting enzyme in endothelial cells [J].
Bzowska, M ;
Jura, N ;
Lassak, A ;
Black, RA ;
Bereta, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (13) :2808-2820